228 related articles for article (PubMed ID: 28509877)
1. Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6⁺CD4⁺ T Cells.
Lafferty MK; Sun L; Christensen-Quick A; Lu W; Garzino-Demo A
Viruses; 2017 May; 9(5):. PubMed ID: 28509877
[TBL] [Abstract][Full Text] [Related]
2. Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin β7.
Monteiro P; Gosselin A; Wacleche VS; El-Far M; Said EA; Kared H; Grandvaux N; Boulassel MR; Routy JP; Ancuta P
J Immunol; 2011 Apr; 186(8):4618-30. PubMed ID: 21398606
[TBL] [Abstract][Full Text] [Related]
3. Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands.
Alvarez Y; Tuen M; Shen G; Nawaz F; Arthos J; Wolff MJ; Poles MA; Hioe CE
J Virol; 2013 Oct; 87(19):10843-54. PubMed ID: 23903844
[TBL] [Abstract][Full Text] [Related]
4. CCR6/CCL20 chemokine axis in human immunodeficiency virus immunity and pathogenesis.
Lee AYS; Körner H
J Gen Virol; 2017 Mar; 98(3):338-344. PubMed ID: 28005525
[TBL] [Abstract][Full Text] [Related]
5. Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.
Bolduc JF; Ouellet M; Hany L; Tremblay MJ
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928019
[TBL] [Abstract][Full Text] [Related]
6. CCR6 ligands inhibit HIV by inducing APOBEC3G.
Lafferty MK; Sun L; DeMasi L; Lu W; Garzino-Demo A
Blood; 2010 Feb; 115(8):1564-71. PubMed ID: 20023216
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection.
Gosselin A; Monteiro P; Chomont N; Diaz-Griffero F; Said EA; Fonseca S; Wacleche V; El-Far M; Boulassel MR; Routy JP; Sekaly RP; Ancuta P
J Immunol; 2010 Feb; 184(3):1604-16. PubMed ID: 20042588
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach.
Cleret-Buhot A; Zhang Y; Planas D; Goulet JP; Monteiro P; Gosselin A; Wacleche VS; Tremblay CL; Jenabian MA; Routy JP; El-Far M; Chomont N; Haddad EK; Sekaly RP; Ancuta P
Retrovirology; 2015 Dec; 12():102. PubMed ID: 26654242
[TBL] [Abstract][Full Text] [Related]
9. Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells.
Wiredja DD; Tabler CO; Schlatzer DM; Li M; Chance MR; Tilton JC
Retrovirology; 2018 Jul; 15(1):44. PubMed ID: 29970186
[TBL] [Abstract][Full Text] [Related]
10. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
Chen K; Huang J; Zhang C; Huang S; Nunnari G; Wang FX; Tong X; Gao L; Nikisher K; Zhang H
J Virol; 2006 Aug; 80(15):7645-57. PubMed ID: 16840343
[TBL] [Abstract][Full Text] [Related]
11. CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals.
Loiseau C; Requena M; Mavigner M; Cazabat M; Carrere N; Suc B; Barange K; Alric L; Marchou B; Massip P; Izopet J; Delobel P
Mucosal Immunol; 2016 Sep; 9(5):1137-50. PubMed ID: 26883727
[TBL] [Abstract][Full Text] [Related]
12. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
[TBL] [Abstract][Full Text] [Related]
13. R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.
Gondois-Rey F; Biancotto A; Fernandez MA; Bettendroffer L; Blazkova J; Trejbalova K; Pion M; Hirsch I
J Virol; 2006 Jan; 80(2):854-65. PubMed ID: 16378987
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection.
El Hed A; Khaitan A; Kozhaya L; Manel N; Daskalakis D; Borkowsky W; Valentine F; Littman DR; Unutmaz D
J Infect Dis; 2010 Mar; 201(6):843-54. PubMed ID: 20144043
[TBL] [Abstract][Full Text] [Related]
15. Trehalose Inhibits Human Immunodeficiency Virus Type 1 Infection in Primary Human Macrophages and CD4
Rawat P; Hon S; Teodorof-Diedrich C; Spector SA
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554696
[TBL] [Abstract][Full Text] [Related]
16. CCL20 and β-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions.
Ghannam S; Dejou C; Pedretti N; Giot JP; Dorgham K; Boukhaddaoui H; Deleuze V; Bernard FX; Jorgensen C; Yssel H; Pène J
J Immunol; 2011 Feb; 186(3):1411-20. PubMed ID: 21178014
[TBL] [Abstract][Full Text] [Related]
17. Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents.
Tuttle DL; Coberley CR; Xie X; Kou ZC; Sleasman JW; Goodenow MM
AIDS Res Hum Retroviruses; 2004 Mar; 20(3):305-13. PubMed ID: 15117454
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
[TBL] [Abstract][Full Text] [Related]
19. The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4(+) T-cell APOBEC3G expression and HIV-1 infectivity.
Pido-Lopez J; Wang Y; Seidl T; Babaahmady K; Vaughan R; Lehner T
Eur J Immunol; 2009 Jul; 39(7):1956-65. PubMed ID: 19585516
[TBL] [Abstract][Full Text] [Related]
20. Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.
Khoury G; Anderson JL; Fromentin R; Hartogenesis W; Smith MZ; Bacchetti P; Hecht FM; Chomont N; Cameron PU; Deeks SG; Lewin SR
AIDS; 2016 Jun; 30(10):1511-20. PubMed ID: 26807971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
